이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
JD Health International 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Enlin Jin
최고 경영자
CN¥8.4m
총 보상
| CEO 급여 비율 | 15.0% |
| CEO 임기 | 2.8yrs |
| CEO 소유권 | 0.01% |
| 경영진 평균 재임 기간 | 데이터 없음 |
| 이사회 평균 재임 기간 | 3.7yrs |
최근 관리 업데이트
Recent updates
This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14
Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends
Dec 07What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?
Nov 20JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 02Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital
Aug 21JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price
Aug 03JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues
Jun 08Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?
Apr 19Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
Dec 29Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?
Sep 14A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Dec 04Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Mar 08CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Dec 31 2023 | CN¥8m | CN¥1m | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥1b |
| Dec 31 2022 | CN¥8m | CN¥1m | CN¥380m |
| Sep 30 2022 | n/a | n/a | -CN¥7m |
| Jun 30 2022 | n/a | n/a | -CN¥395m |
| Mar 31 2022 | n/a | n/a | -CN¥734m |
| Dec 31 2021 | CN¥3m | CN¥301k | -CN¥1b |
보상 대 시장: Enlin 의 총 보상 ($USD 1.15M )은 Hong Kong 시장( $USD 883.87K ).
보상과 수익: Enlin 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Enlin Jin (43 yo)
2.8yrs
테뉴어
CN¥8,385,000
보상
Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 2.8yrs | CN¥8.39m | 0.010% CN¥ 7.0m | |
| Independent Non-Executive Director | 2.3yrs | CN¥818.00k | 0.00030% CN¥ 203.3k | |
| Chairman | 3.8yrs | CN¥407.82m | 0.28% CN¥ 188.7m | |
| Non-Executive Director | 3.9yrs | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 3.7yrs | CN¥476.00k | 0.00018% CN¥ 122.0k | |
| Independent Non-Executive Director | 3.7yrs | CN¥476.00k | 0.00018% CN¥ 122.0k | |
| Independent Non-Executive Director | 3.3yrs | CN¥463.00k | 0.00019% CN¥ 128.8k |
3.7yrs
평균 재임 기간
51yo
평균 연령
경험이 풍부한 이사회: 6618 의 이사회는 경험(평균 재직 기간 3.6 년)으로 간주됩니다.